Science

AddToAny

Google+ Facebook Twitter Twitter

Australia's battle with Covid

Professor Adrian Esterman, Chair of Biostatistics and Epidemiology at the University of South Australia, looks at the current situation.

Australia is always touted as the “Lucky Country”, and to a large extent that is true. It has remained pretty much unscathed with respect to COVID-19, with just over 30,000 cases and just over 900 deaths. As I pointed out in my article 12 months ago, this was largely due to the quick closure of borders early last year and very good compliance with social distancing and hygiene regulations by the Australian public. Contact tracing in each state has also been exceptional. However, two problems are now rearing their ugly heads – hotel quarantine and the vaccination roll-out.

Hotel quarantine

When the epidemic first started last year and our borders were closed, we had two problems – a lot of empty hotels and thousands of Australians who were currently overseas and desperately wanted to return. So, a decision was made to quarantine them in the near-empty hotels. At the time, it was quite a good solution, and we did not know then how readily the virus can be passed on by aerosol.  However, all recent outbreaks, including the current one in Victoria, have been caused by leaks from the quarantine hotels.

Please click here to read the full article.

Image Credit | iStock

Related Articles

Medical Science Laboratory with Diverse Multi-Ethnic Team of Microbiology Scientists Have Meeting on Developing Drugs, Medicine, Doing Biotechnology Research-CREDIT_istock-1293772951

Equity, diversity and inclusion for all

Jemma Shead, a Senior Biomedical Scientist at Synnovis and IBMS EDI Working Group member, on how and why you should get involved with EDI.

adeno associated virus capsid-Image Credit | Science Photo Library - c0142837

Examining the medical mystery of child hepatitis outbreak

A study has shed light on an unexpected wave of severe acute hepatitis cases in 2022, amid the backdrop of the ongoing global COVID-19 pandemic.

clostridioides difficile bacteria-Image Credit | Science Photo Library - c0016337

Faecal microbiota transplant for C. diff

In the first comprehensive US evidence-based guideline on the use of faecal microbiota-based therapies for gastrointestinal disease, the American Gastroenterological Association recommends faecal microbiota transplant (FMT) for most patients with recurrent Clostridioides difficile (C. diff) infection.

pseudomonas aeruginosa bacteria Image-Credit | Science Photo Library - f0381226

Tackling priority pathogen with phages

A new study describes the use of phage therapy to eradicate multidrug-resistant Pseudomonas aeruginosa infections in vivo with important new implications for antibiotic resistance.

Top